Clinical Trials Logo
  1. Home
  2. Opioid-use Disorder
  3. NCT05729932
  4. Details
NCT05729932 Clinical Trial

Cannabis and Opioid Use Disorder

Opioid Use Disorder Clinical Trial

Official title:
Cannabis Modulation of Outcomes Related to Opioid Use Disorder: Opioid Withdrawal, Abuse Potential and Safety

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05729932
Other study ID # 75562-20222
Secondary ID 1R01DA054347
Status Not yet recruiting
Phase Phase 1
First received
Last updated
Start date June 2024
Est. completion date June 2027

Study information
Verified date February 2024
Source University of Kentucky
Contact Paul Nuzzo, MA
Phone 859-323-0002
Email pnuzz2@email.uky.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study plans to enroll participants with opioid use disorder who are not currently seeking treatment to assess the effects of cannabis on opioid withdrawal and other related outcomes.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 15
Est. completion date June 2027
Est. primary completion date June 2027
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Current opioid use disorder Exclusion Criteria: - Current medical conditions that require medical management

Study Design

Related Conditions & MeSH terms

Intervention

Drug:
• Inhaled vaporized cannabis
Double-blind cannabis and placebo doses, administered through vaporizer
• Intransal opioid
Double-blind opioid and placebo doses, administered intranasal route

Locations
Country Name City State
n/a

Sponsors (2)
Lead Sponsor Collaborator
University of Kentucky National Institute on Drug Abuse (NIDA)

Outcome
Type Measure Description Time frame Safety issue
Primary Change from Baseline - Opioid Withdrawal Severity - Visual Analog Scale (VAS) Subjective ratings of opioid withdrawal severity on visual analog scale (scale 0-100; 0 = not at all, 100 = extremely) Change from baseline
Secondary Change from Baseline - Opioid Drug Liking - Visual Analog Scale (VAS) Subjective ratings of drug liking on visual analog scale (scale 0-100, 0 = not at all, 100 = extremely) Change from baseline
Secondary Change from Baseline - Respiration Physiological monitoring of respiration rate (breaths per minute) Change from baseline
See also
  Status Clinical Trial Phase
Recruiting NCT06021431 - Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT N/A
Completed NCT06266572 - Overcoming Stigma and Improving Outcomes for SUDs Through Education, Engagement, and Empowerment Phase 1
Recruiting NCT05037682 - Pain and Opioid Management in Older Adults N/A
Completed NCT06200740 - Remotely Observed Methadone Evaluation N/A
Not yet recruiting NCT06441604 - Extended-release Buprenorphine as a Novel Low-dose Induction Strategy Phase 2
Recruiting NCT06028126 - Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial N/A
Completed NCT02559973 - Pharmacokinetics, Safety, and Tolerability of Depot Buprenorphine at Three Different Molecular Weights in Treatment-Seeking Subjects With Opioid Use Disorder Phase 1
Completed NCT02440256 - Expanded HIV Care in Opioid Substitution Treatment (EHOST) Trial N/A
Completed NCT02593474 - Medication-Assisted Treatment for Youth With Substance Use Disorders Phase 1
Completed NCT05587998 - A Study to Assess the Effect of AZD4041 on Respiratory Drive in Recreational Opioid Users. Phase 1
Terminated NCT04577144 - An Observational Study of Environmental and Socioeconomic Factors in Opioid Recovery - Long Term
Recruiting NCT06001437 - Following Outcomes Remotely Within Addiction Recovery Domains
Recruiting NCT05976646 - Phase Ib/2a Drug-drug Interaction Study of a Combination of 45mg Dextromethorphan With 105 mg Bupropion Phase 1/Phase 2
Completed NCT05546229 - Assessment of Methadone and Buprenorphine in Interstitial Fluid
Not yet recruiting NCT06416020 - Integrating MOUD in African American Community Settings (Better Together) N/A
Not yet recruiting NCT06104280 - Medications for Opioid Use Disorder Photosensitive Retinal Ganglion Cell Function, Sleep, and Circadian Rhythms: Implications for Treatment N/A
Recruiting NCT06206291 - Cannabidiol for Opioid Addiction Phase 2
Completed NCT05552040 - START NOW in the Treatment of Opioid Addicted Individuals N/A
Recruiting NCT05459922 - Adjunctive Bright Light Therapy for Opioid Use Disorder N/A
Recruiting NCT05343169 - Community-based Education, Navigation, and Support Intervention for Military Veterans N/A